A growing body of research has elucidated that IL-6 rs1800795 is linked with increased vulnerability to multiple cancers (Harun-Or-Roshid et al. 2021) as well as the prognosis of several malignancies such as NSCLC, ovarian, bladder, neuroblastoma, and breast cancer (Almolakab et al. 2022; Zhai et al. 2017). This evidence concerns the gene IL6 and non-small cell lung carcinoma.